Sunesis Pharmaceuticals (SNSS) Issues Update on Meetings with EMA, FDA Over Vosaroxin in AML
Tweet Send to a Friend
Sunesis Pharmaceuticals (NASDAQ: SNSS) announced regulatory updates from its interactions with the European Medicines Agency (EMA) and U.S. Food and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE